{
    "2021-09-29": [
        [
            {
                "time": "",
                "original_text": "贝达药业：目前CM082针对肾癌适应症的新药注册申报准备工作正在推进中",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "CM082",
                        "肾癌",
                        "新药注册"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：公司及控股子公司的主营业务为研发、生产、销售具有自主知识产权的创新药产品，暂未对外提供CRO方面的研究服务",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "主营业务",
                        "创新药",
                        "CRO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：CM082是针对VEGFR和PDGFR靶点的多靶点受体酪氨酸激酶（RTKs）抑制剂，基于对新生血管生成的抑制作用，在前期的临床研究中发现了CM082对于湿性年龄相关性黄斑变性的治疗作用",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "CM082",
                        "VEGFR",
                        "PDGFR",
                        "靶点",
                        "临床研究",
                        "黄斑变性"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：板块性价比渐突出 Q3业绩延续较好增长趋势",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "性价比",
                        "Q3业绩",
                        "增长趋势"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "是否符合第五套上市标准相关要求？益方生物科创板IPO回复这样论证",
                "features": {
                    "keywords": [
                        "第五套上市标准",
                        "益方生物",
                        "科创板",
                        "IPO"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}